CG Oncology Inc. (CGON) Financials

CGON Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 1.1 billion 56.5 million
March 31, 2026 1.1 billion 43.5 million
Dec. 31, 2025 791.6 million 39.0 million
Sept. 30, 2025 729.9 million 42.3 million

CGON Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -46.9 million 14.3 million
March 31, 2026 -57.2 million 6.5 million
Dec. 31, 2025 -36.2 million 7.2 million
Sept. 30, 2025 -39.0 million 7.3 million

CGON Net Income

No data available :(

CGON Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 1.0 billion 3.0 million 5.8 million
March 31, 2026 1.1 billion 3.0 million 4.6 million
Dec. 31, 2025 742.2 million 3.0 million 4.0 million
Sept. 30, 2025 680.3 million 3.0 million 4.2 million

CGON Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 88.2 million
March 31, 2026 84.5 million
Dec. 31, 2025 77.3 million
Sept. 30, 2025 76.7 million

CGON Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 468000 54.7 million 29.0 million -
March 31, 2026 304000 43.7 million 20.8 million -
Dec. 31, 2025 7000 30.0 million 18.0 million -
Sept. 30, 2025 97000 27.9 million 23.3 million -

CGON Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 1.2 million 3.9 million
March 31, 2026 1.1 million 3.0 million
Dec. 31, 2025 2.3 million 2.9 million
Sept. 30, 2025 1.7 million 1.6 million

CGON Revenue by Segment
Graph available only for paid members. Upgrade to see it.

CGON

Price: $75.03

52 week price:
23.65
79.39

Earnings Per Share: -2.69 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 6.8 billion

Links: